GO
Loading...

Government Agencies

More

  • The FDA nonetheless approved it for short-term use because other trials did not show a similar so-called cardiovascular safety signal.

  • *Follows US settlement with Credit Suisse. JERUSALEM, June 8- Bank Leumi, Israel's second largest bank, said on Sunday it was close to a deal to pay nearly 1 billion shekels to the U.S. Justice Department in relation to its investigation into possible tax evasion by the bank's American clients.

  • DIARY - Top Economic Events to June 20 Friday, 6 Jun 2014 | 8:01 PM ET

    ASTANA/ ALMATY/ KYZYLORDA- European Bank for Reconstruction and Development President Sir Suma Chakrabarti visits Kazakhstan. PALM BEACH, United States- Federal Reserve Bank of St. Louis President James Bullard speaks on the U.S. economy and monetary policy before the Tennessee Bankers Association annual meeting- 1310 GMT.

  • *See for data on primary dealers. June 6- A majority of Wall Street's top bond firms don't see the Federal Reserve raising interest rates before the second half of next year and most also now believe the Fed won't start shrinking its massive balance sheet before it lifts rates, a Reuters survey showed on Friday.

  • PRIMARY DEALERS SAY FEDERAL RESERVE WON'T RAISE INTEREST RATES BEFORE SECOND HALF 2015- REUTERS SURVEY.

  • WASHINGTON, June 6- The U.S. Food and Drug Administration said on Friday it approved Biogen Idec Inc's long-lasting hemophilia A drug, Eloctate, adding another product to the company's nascent portfolio of drugs for non-malignant blood disorders. The FDA's ruling followed its approval in March of Biogen's hemophilia B treatment, Alprolix.

  • Here's your chance to follow the CIA Friday, 6 Jun 2014 | 2:55 PM ET

    The CIA has a Twitter account—and a sense of humor, apparently, NBC News reports.

  • NEW YORK, June 6- The U.S. dollar recouped losses Friday as investors added to a well-worn pattern of borrowing greenbacks to buy higher-yielding currencies after solid U.S. jobs data left little chance the Federal Reserve would speed up monetary tightening.

  • INVESTMENT FOCUS -Exploiting the ECB-Fed policy gap Friday, 6 Jun 2014 | 10:19 AM ET

    LONDON, June 6- If it wasn't fully apparent before Thursday, it's crystal clear now: the central banks of the euro zone and United States, the two most powerful monetary authorities in the world, are moving in opposite directions.

  • Senators make veterans deal; 18 deaths confirmed Friday, 6 Jun 2014 | 8:39 AM ET
    Sen. John McCain (R-AZ) talks to reporters after a closed door briefing June 4, 2014 on Capitol Hill in Washington.

    As the Senate made a deal to ease delays, the VA's acting boss revealed 18 veterans on a secret waiting list died while waiting for care.

  • LONDON, June 6- Federal Reserve Governor Jerome Powell said on Friday that he wanted to see signs that the U.S. economy was tightening up before before interest rates could be raised. While acknowledging that employment in the United States had rebounded, Powell highlighted "significant" slack, referring to unemployed or underutilized workers.

  • LONDON, June 6- Federal Reserve Governor Jerome Powell said on Friday that the U.S. central bank's forward guidance on interest rates has boosted the U.S. economy by keeping medium- and long-term borrowing costs lower than they otherwise would have been.

  • BOSTON/ SAN FRANCISCO, June 5- A pair of Federal Reserve officials on Wednesday warned that raising U.S. interest rates to fend off bubbles and other troubling signs of financial market unrest could undercut the Fed's efforts to put the U.S. economy on a sounder footing.

  • WASHINGTON, June 5- U.S. household net worth nudged up 2 percent to a record high $81.8 trillion in the first quarter as the stock market continued its upward climb and property values rose, data from the Federal Reserve showed on Thursday.

  • Halozyme shares jump after FDA lifts hold on trial Thursday, 5 Jun 2014 | 7:52 AM ET

    June 5- Shares of Halozyme Therapeutics Inc jumped about 11 percent a day after the U.S. Food and Drug Administration lifted a hold on a trial testing an advanced version of the company's flagship drug delivery technology.

  • WASHINGTON, June 4- Kentucky may be well positioned to meet a carbon emission target for power plants set by federal regulators, even as U.S. Senate candidates there blast the plan, saying it will cripple the state's coal industry. The result: the Bluegrass State may be able to meet EPA targets between now and 2030..

  • NEW YORK/ WASHINGTON, June 4- The Federal Reserve may scrap elements of international measures aimed at assessing bank health in favor of imposing its own rules, frustrating bankers who have spent billions of dollars retooling their books to meet global standards.

  • June 4- HeartWare International Inc said it received a warning letter from the U.S. Food and Drug Administration following an inspection of its manufacturing plant in Florida in January. HeartWare has also been asked to address issues related to its production and quality procedures and fix problems cited in FDA's inspection.

  • Medical device maker HeartWare gets FDA warning letter Wednesday, 4 Jun 2014 | 7:37 AM ET

    June 4- HeartWare International Inc said it received a warning letter from the U.S. Food and Drug Administration following an inspection of its manufacturing plant in Florida in January. The FDA has not restricted the use of HeartWare devices, the company said in a statement.

  • Under Basel, banks can determine how much debt they can take on by using their own models and computer systems to calculate how risky their assets are, among other methods. In other words, the Basel rules give banks a chance to monkey with their risk models to boost profit.